Business CBD/Hemp Crime Health & Medicine Law News

Feds Send Warning Letter To CBD Company Over Medical Claims

The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) sent a warning letter to a Florida-based CBD company on Tuesday, alleging that the business made several unsanctioned claims about the therapeutic benefits of their products.

The federal agencies accused Rooted Apothecary of unlawfully asserting that their cannabidiol products could treat symptoms of conditions such as ADHD, Parkinson’s disease, ear aches, ADHD and autism. Those claims appeared on the company’s website and social media accounts, they said.

Certain products appeared to be marketed as dietary supplements, which FDA currently prohibits as it works to develop an alternative regulatory scheme for CBD.

“Cannabis and cannabis-derived compounds are subject to the same laws and requirements as FDA-regulated products that contain any other substance,” Acting FDA Commissioner Ned Sharpless said in a press release. “We are working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat, or cure a number of diseases or conditions.”

To Read The Rest Of This Article By Kyle Jaeger on Marijuana Moment

Published: October 22, 2019

SHARE
RELATED POSTS
Dion Waiters suspended 10 games by Heat for edible marijuana incident on team plane
Palm Springs is Accepting Cannabis Applications with No Deadline!
California Dramatically Cuts Cannabis Tax Revenue Projections

Leave Your Reply

*